lymphocytic leukemia

Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to lymphocytic leukemia: acute lymphocytic leukemia
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.lymphocytic leukemia - leukemia characterized by enlargement of lymphoid tissues and lymphocytic cells in the circulating blood
cancer of the blood, leucaemia, leukaemia, leukemia - malignant neoplasm of blood-forming tissues; characterized by abnormal proliferation of leukocytes; one of the four major types of cancer
lymphoblastic leukemia - a form of lymphocytic leukemia in which the abnormal cells in the circulating blood are almost totally lymphoblasts
References in periodicals archive ?
M2 PHARMA-December 12, 2017-Chronic Lymphocytic Leukemia Patients Report Long-Term Benefits of Treatment with Imbruvica
USPRwire, Wed Oct 25 2017] This report provides comprehensive information on the therapeutic development for Refractory Chronic Lymphocytic Leukemia (CLL), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
Background: The established clinical staging systems (Rai/Binet) of chronic lymphocytic leukemia (CLL) cannot accurately predict the appropriate treatment of patients in the earlier stages.
Objective: Chronic lymphocytic leukemia (CLL) is a heterogeneous disease in terms of survival with and without treatment.
announced today that the anticancer agent TREAKISYM for Injection 100 mg (generic name: bendamustine hydrochloride, "TREAKISYM") has been approved in Japan for an additional indication of chronic lymphocytic leukemia.
Global Markets Direct's, 'Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016', provides an overview of the Chronic Lymphocytic Leukemia (CLL) pipeline landscape.
M2 EQUITYBITES-March 7, 2016-AbbVie passes US FDA approval for IMBRUVICA (ibrutinib) for first-line treatment for patients with chronic lymphocytic leukemia
Being a mature B cell malignancy, the finding of monoclonal proteins is not unexpected in chronic lymphocytic leukemia (CLL).
Chronic lymphocytic leukemia (CLL) and diffuse large Bcell lymphoma (DLBCL) are 2 of the most common Bcell malignancies in adults, affecting almost 50 000 and more than 20 000 patients, respectively, in the United States each year.
UKPRwire, Fri Sep 13 2013] Global Markets Direct's, 'Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline.
Introduction: Chronic lymphocytic leukemia (CLL) is characterized by the progressive accumulation of B cells with mature appearance and a distinctive immunophenotype in peripheral blood, bone marrow, lymph nodes and other lymphoid tissues.

Full browser ?